Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

NACIA Biotechnology AB

Closing information (x1000 NOK)

Closing information 2023/12 2021/12 2020/12
Turnover 0 Equal arrow 0 More Arrow 313
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -225 More Arrow -19 Less Arrow -42
EBITDA -225 More Arrow -21 Less Arrow -44
Total assets 2,532 Less Arrow 2,467 More Arrow 2,654
Current assets 2,532 Less Arrow 2,467 More Arrow 2,654
Current liabilities 2,838 Less Arrow 2,481 More Arrow 2,640
Equity capital -306 More Arrow -6 More Arrow 14
- share capital 101 Less Arrow 98 More Arrow 105
Employees (average) 2 Equal arrow 2 Less Arrow 0

Financial ratios

Fiscal year 2023/12 2021/12 2020/12
Solvency -12.1% More Arrow -0.2% More Arrow 0.5%
Turnover per employee 0 Equal arrow 0
Profit as a percentage of turnover -13.4%
Return on assets (ROA) -8.9% More Arrow -0.8% Less Arrow -1.6%
Current ratio 89.2% More Arrow 99.4% More Arrow 100.5%
Return on equity (ROE) 73.5% More Arrow 316.7% Less Arrow -300%
Change turnover 0 Less Arrow -292 More Arrow 313
Change turnover % -100%
Chg. No. of employees 0 More Arrow 2 Less Arrow -2
Chg. No. of employees % 0% -100%

Total value of public sale

Fiscal year 2023/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.